Introduction
Fibrinogen (Fbg)', fibrin, and degradation products of these plasma proteins (FDP) have important effects on several 1 . Abbreviations used in this paper: DIC, disseminated intravascular coagulation; Fbg, fibrinogen; FDP, fibrinogen degradation products; KGEP, homogenizing buffer consisting of 139 mM potassium glutamate, 20 mM Pipes, pH 6.6, 5 mM EGTA, 5 mg/ml BSA, and 50 .ug/ml leupeptin; OAG,' l-oleoyl-2-acetylglycerol; PDBU, phorbol-12,13-dibutyrate; PKC, protein kinase C; PMA, phorbol myristate acetate; ZAS, zymosan activated serum. aspects of inflammation. Perhaps most thoroughly studied is their role in platelet activation. In many circumstances, occupancy of platelet Fbg receptors with intact Fbg precedes platelet secretion and aggregation which support normal hemostasis (1) (2) (3) . Elevation in plasma FDP, such as in disseminated intravascular coagulation (DIC) or adult respiratory distress syndrome, may inhibit the interaction between platelet Fbg receptors and Fbg and contribute directly to platelet dysfunction and bleeding diathesis (4) (5) (6) . Several studies suggest that FDP may also have deleterious effects on other cells involved in acute inflammation. Fragment D, a -100-kD plasmin-generated FDP, induces cytoskeletal alterations and eventual retraction of venous endothelial cells in vitro (7, 8) . Fragment E, a -50-kD FDP, competes with Fbg for fibroblast Fbg binding sites and inhibits directed migration of these cells in a Fbg concentration gradient (9, 10) . Low molecular weight Fbg degradation products have been shown to decrease lymphocyte blastogenesis (1 1, 12) . With regard to PMN, various low molecular weight (< 20 kD) polypeptides derived from Fbg have been found to induce chemotaxis (13) . Possible PMN chemotactic activity of fragment D has also been reported (14, 15) . Human fibrinopeptide B has chemotactic activity for PMN in potency equivalent to that of O~a, leukotriene B4, and FMLP (16) . These observations suggest that increases in the plasma concentration of various Fbg fragments modify the inflammatory response by virtue of their effects on multiple cellular components ofblood. Because clinical situations in which DIC occurs are commonly associated with severe bacterial infections and neutropenia (17) , we initiated studies to define more clearly the effects of FDP and related activated coagulant proteins on PMN functions related to host defense against bacteria.
Methods
Preparation ofFbg and FDP. Lyophilized human Fbg (Imco, Stockholm, Sweden) was dissolved in distilled water and dialyzed against 0.01 M PBS, pH 7, for 18 h at 4VC. Dialyzed Fbg was stored at -20'C until use. To prepare FDP, Fbg was incubated with plasmin (0.0025 mg/ml final concentration) at 370C for 1-3 h. Proteolysis was stopped by addition oftosyllysyl chloromethyl ketone and phenylalanylarginyl chloromethyl ketone (Sigma Chemical Co., St. Louis, MO), followed by dialysis at 4VC against PBS and sodium azide (18) . Mixed D and E fragments were separated from lower molecular weight degradation products by passage ofthe preparations over a Sephadex G150 column (80 X 2.5 cm). FDP was dialyzed against PBS before use. The presence of D and E fragments was verified by SDS-PAGE run under nonreducing conditions. These preparations displayed characteristic bands of 80-100 (fragments D1,2,3) and 50 kD (fragment E), and minor components between 50 and 100 kD after staining with Coomassie blue (Fig. 1) (18-20) . In (27) .
Superoxide production. Superoxide production was measured by SOD-inhibitable cytochrome c reduction (28). PMN Effect of FDP on PKC activation by phorbol esters. The effect of FDP on PMN PKC activation was compared with that of BSA using the method of TerBush and Holz (39) . PMN (107) were incubated in HBSS with 10-8 M PMA in the presence of either FDP or BSA (100 Mug/ml) for 10 min at 370C. The cells were then washed three times in HBSS and resuspended in 0.4 ml cold (40C) homogenizing buffer consisting of 139 mM potassium glutamate, 20 mM Pipes, pH 6.6, 5 mM EGTA, 5 mg/ml BSA, and 50 ug/ml leupeptin (KGEP) as described (40) . The suspensions were sonicated twice (setting of 7 for 10s; Kontes Co., Vineland, NJ) and subjected to centrifugation at 148,000 g for 10 min. The supernatant (containing cytosol) was removed. The pellet (containing membranes) was washed twice in cold KGEP, resuspended in KGEP with trituration, and Triton X-100 added to both pellet and supernatant to a final concentration of 0.1%. 20 ul of each fraction was then added to a protein kinase C (PKC) assay solution containing 42 mM potassium glutamate, 20 mM Pipes (pH 6.6), 10 mM MgCl2, 10 mM DTT, 0.016% Triton X-100, 50,ug histone/ml, 0.8 mg BSA/ml, ±0.8 mM CaCI2, ±167 Mg phosphatidylserine/ml, ±26. (25, 26) . PMN were then sonicated, aliquots plated on blood agar, and bacterial colonies counted after incubation for 24 h at 370C.
$ Results represent the mean of triplicates. ND, not done.
Effects ofplasma coagulant proteins on FMLP-stimulated PMN°2 release. Incubation of PMN with FDP (10-100 ,tg/ml), Fbg ,g/ml), plasmin (10 Atg/ml), thrombin (1 or 10 U/ml), or BSA (100 ,ug/ml) for 10 min did not result in detectable O2 release. Cell viability as assessed by trypan blue exclusion was > 98% before and after addition of each of the proteins.
When 5 X I0-' M FMLP was added to PMN suspended in 100 gg/ml BSA, 2.5-22.5 nmol O2/10 min was released. Substitution of BSA with an equivalent concentration of FDP resulted in a 49-57% reduction of FMLP-stimulated O2 accumulation using PMN of six donors (P < 0.005 by paired t test, Fig. 2 ). The ranges for triplicate determinations represented by the mean values in this figure and Fig. 3 vary < 10% from the mean in every case. For example, the mean of 22.5 nmol 0O/10 min (the highest point under CONT. in Fig. 2 ) was calculated from values ranging from 21 to 23 nmol 0/10 mmin. In contrast to FDP, Fbg (100 ,ug/ml), thrombin (1 or 50 U/ml), or plasmin (10 ,g/ml) did not affect the amount of FMLP-induced PMN O2 release compared with cells incubated with 100 ,ug/ml BSA (range of 5 to 15 nmol 0O/10 min in five experiments comparing coagulant proteins with BSA). The inhibitory effect of FDP on FMLP-induced°2 release was not observed when FDP were removed before addition of the activating ligand. PMN were preincubated with 100 ,ug/ml FDP for 10 min at 37°C, washed three times in HBSS, and 5 X 10-7 FMLP added. A total of 9.8, 11.6, and 13.0 nmol 0-/10 min concentration of 50 jug/ml suppressed O2 release from PMN of a third donor by 21% (29.1±3.0 in the presence of 50 ,g/ml BSA vs. 22 .0±3.0 nmol/10 min, P < 0.05).
Capacity of FDP to reverse FMLP-induced PMN O2 release. To ascertain whether FDP could abrogate O2 production from PMN previously exposed to FMLP, 100 ,g/ml FDP or control BSA was added to cells 1.5 or 5.5 min after 5 X l0-' M FMLP. Addition of BSA 1.5 (Fig. 4, closed (Table II) . There were no differences in the effects of Fbg and BSA on PMN binding of FMLP (Table II) . To define in more detail the possible interaction of FDP with FMLP receptors, additional experiments were performed in conditions limiting PMN internalization of FMLP and coagulant proteins and over a broad concentration range of radiolabeled ligand (1.3-85 nM [3H]FMLP). In the presence of 100 ,g/ml BSA (control protein), PMN were calculated to have high affinity FMLP receptors with Kd = 2.8 x 10-9 M and low affinity receptors with Kd = 1.5 X l0-M (curve generated from triplicate determinations of six points) (Fig. 5) . Parallel studies con- FDP reduced directed migration of PMN by 32-48% compared with BSA. A chemotactic index of 3.4±0.4 (mean±SE) was obtained for control PMN incubated with BSA vs. 2.0±0.3 for those with FDP (P < 0.01) ( Table III) . The chemotactic indices ofPMN incubated with Fbg (100 pg/ml), thrombin (50 U/ml), or plasmin (10 pg/ml) did not differ significantly from controls (data not shown for latter two proteins).
FDP modification of PMN 02 release induced by additional nonphagocytic and phagocytic stimuli. To examine whether the inhibitory effect of FDP occurred under circumstances involving other nonphagoytic stimuli, studies were conducted with PMA, OAG, AA, and ZAS. PMA and OAG may stimulate the respiratory burst primarily through direct activation and translocation of PKC (41), while the mechanism by which AA induces PMN O2 release is not well established (42) . ZAS containing C5a presumably stimulates PMN respiratory burst activity by a pathway similar to that for other ligands having surface PMN receptors (e.g., FMLP). When 10 ng/ml PMA was added to PMN, 02 release was 20-74% lower in the presence of 100 pg/ml FDP vs. an equal concentration of BSA (P < 0.001, Table IV ). Unlike the situation with FMLP, however, addition of FDP 1.5 min after PMA did not inhibit PMN Oj release (data not shown). Stimulation of (63) * PMN were incubated with 100 ,g/ml BSA or FDP and PKC activity was measured after exposure to buffer alone (unstimulated) or I0O-PMA (39, 40) . This value represents the mean of triplicate determinations. The number within the parentheses represents the percent PKC activity in the soluble (cytoplasmic) fraction of PMN sonicates subjected to centrifugation at 148,000 g for 10 min. "P < 0.05 compared with unstimulated PMN.
bound by PMN when the assay was performed in the presence of BSA or FDP (Table II) .
PKC activation.-FDP completely abrogated PKC activation by PMA in intact PMN. When 10-8 M PMA was added to PMN coincubated with 100 ,g/ml FDP, there was no change in total PKC activity or the proportion in soluble fractions of PMN sonicates (65 and 72% for unstimulated cells). In contrast, when PMN were coincubated with 100 ug/ml BSA, PMA caused a 23-41% increase in total PKC activity (P < 0.05) and one-third to one-half reduction in the proportion in soluble fractions (Table V) . Cells not exposed to protein or PMA had values that were identical to those incubated with BSA (e.g., 400±35 pmol P/10 min per I0' PMN with no protein or PMA vs. 380±40 pmol P/10 min per 107 PMN with 100 ,g/ml BSA; triplicate samples for each with cells of one donor).
Discussion
Fbg and several proteolytic fragments of this plasma protein have important effects on circulating PMN. Low molecular weight (< 20 kD) fragments produced by extensive plasmin digestion are chemotactic for rabbit PMN in vitro and induce egress from the vascular space in vivo (43, 44) . Fibrinopeptide B, a thrombin-derived cleavage product of Fbg BB chains, is also chemotactic but does not stimulate degranulation or respiratory burst activity (16) . The (53, 54) , directly Activate PKC in some circumstances (55, 56) , and is a required cofactor for NADPH oxidase activity prepared from broken resting PMN (57, 58 (64) .
